From: Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study
Coefficient | P value | Odds ratio | 95% CI | ||
---|---|---|---|---|---|
Intercept | -1.71 | <0.0001 | |||
Gender (ref = male) | 0.05 | 0.009 | 1.05 | 1.01 | 1.10 |
Age (ref = <65) | 0.18 | <0.0001 | 1.2 | 1.11 | 1.3 |
Health care consumption (ref = >4 consultations/year) | 0.57 | <0.0001 | 1.76 | 1.62 | 1.92 |
Cardiovascular diseases (ref = no) | 0.22 | <0.0001 | 1.25 | 1.17 | 1.33 |
Arthropathic diseases (ref = no) | 0.07 | 0.009 | 1.07 | 1.01 | 1.13 |
Anxiety (ref = no) | 1.98 | <0.0001 | 7.29 | 5.86 | 9.05 |
Depression (ref = no) | 1.95 | <0.0001 | 7.03 | 6.03 | 8.2 |
Insomnia (ref = no) | 2.22 | <0.0001 | 9.25 | 7.26 | 11.7 |
Gender*age | 0.24 | <0.0001 | |||
Gender * Health care consumption | - 0.09 | 0.017 | |||
Age* Cardiovascular diseases | -0.14 | 0.009 | |||
Age* Depression | -0.51 | <0.0001 | |||
Anxiety *Depression | -1.19 | <0.0001 | |||
Depression*Insomnia | - 0.68 | 0.007 |